As diagnostic tools improve, it’s becoming increasingly clear that transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure. Dr. Ariane de Hoog, Head of Pharma Dynamic Shared Ownership Communications at Bayer, shares her deeply personal story about her mother’s struggle to get diagnosed with ATTR-CM, and how this experience shaped Ariane´s commitment to Bayer´s mission, #HealthForAll, #HungerForNone. A lack of awareness around ATTR-CM contributes to its underdiagnosis as a cause of heart failure. 🔗 Watch the full video of Ariane’s journey, along with the personal stories of other #TeamBayer employees. Check the comments below for the link! 👇 #InspiredByYou
Thank you, Ariane, for sharing your personal story and shedding light on the importance of awareness and diagnosis of ATTR-CM. 👏 It's heartbreaking to hear about your mother's journey, but it's inspiring to see how it's fueled your commitment to Bayer's mission. ❤️ Looking forward to watching the full video and hearing the stories of other Team Bayer employees.💡 #HealthForAll #HungerForNone"
Estudiante en Universitat de València
2dAriane, your commitment to raising awareness about this disease is truly inspiring ❤️ . The story you have shared is a powerful reminder of how important is to shed light on diseases that too often go unnoticed. I hope this video helps foster greater understanding, earlier diagnosis and better care for those affected. We need more voices like yours to keep driving awareness for rare diseases. 👏